» Articles » PMID: 32505812

Real-Time Prediction of Acute Kidney Injury in Hospitalized Adults: Implementation and Proof of Concept

Abstract

Rationale & Objective: Acute kidney injury (AKI) is diagnosed based on changes in serum creatinine concentration, a late marker of this syndrome. Algorithms that predict elevated risk for AKI are of great interest, but no studies have incorporated such an algorithm into the electronic health record to assist with clinical care. We describe the experience of implementing such an algorithm.

Study Design: Prospective observational cohort study.

Setting & Participants: 2,856 hospitalized adults in a single urban tertiary-care hospital with an algorithm-predicted risk for AKI in the next 24 hours>15%. Alerts were also used to target a convenience sample of 100 patients for measurement of 16 urine and 6 blood biomarkers.

Exposure: Clinical characteristics at the time of pre-AKI alert.

Outcome: AKI within 24 hours of pre-AKI alert (AKI).

Analytical Approach: Descriptive statistics and univariable associations.

Results: At enrollment, mean predicted probability of AKI was 19.1%; 18.9% of patients went on to develop AKI. Outcomes were generally poor among this population, with 29% inpatient mortality among those who developed AKI and 14% among those who did not (P<0.001). Systolic blood pressure<100mm Hg (28% of patients with AKI vs 18% without), heart rate>100 beats/min (32% of patients with AKI vs 24% without), and oxygen saturation<92% (15% of patients with AKI vs 6% without) were all more common among those who developed AKI. Of all biomarkers measured, only hyaline casts on urine microscopy (72% of patients with AKI vs 25% without) and fractional excretion of urea nitrogen (20% [IQR, 12%-36%] among patients with AKI vs 34% [IQR, 25%-44%] without) differed between those who did and did not develop AKI.

Limitations: Single-center study, reliance on serum creatinine level for AKI diagnosis, small number of patients undergoing biomarker evaluation.

Conclusions: A real-time AKI risk model was successfully integrated into the EHR.

Citing Articles

Non-linear association between AKI alert detection rate by physicians and medical costs.

Ai H, Jiang E, Wang H, Yang Q, Jin Q, Wan L PLoS One. 2025; 20(2):e0314907.

PMID: 40009619 PMC: 11864515. DOI: 10.1371/journal.pone.0314907.


Exploring the role of ferroptosis-related genes as biomarkers in acute kidney injury.

Luo G, Gao Y, Zheng Z, Gao B, Wang L, Tang X PLoS One. 2024; 19(7):e0307472.

PMID: 39042632 PMC: 11265698. DOI: 10.1371/journal.pone.0307472.


Time Series AI Model for Acute Kidney Injury Detection Based on a Multicenter Distributed Research Network: Development and Verification Study.

Heo S, Kang E, Yu J, Kim H, Lee S, Kim K JMIR Med Inform. 2024; 12:e47693.

PMID: 39039992 PMC: 11263760. DOI: 10.2196/47693.


The Road to Precision Medicine for Acute Kidney Injury.

Birkelo B, Koyner J, Ostermann M, Bhatraju P Crit Care Med. 2024; 52(7):1127-1137.

PMID: 38869385 PMC: 11250999. DOI: 10.1097/CCM.0000000000006328.


A novel explainable online calculator for contrast-induced AKI in diabetics: a multi-centre validation and prospective evaluation study.

Ma M, Wan X, Chen Y, Lu Z, Guo D, Kong H J Transl Med. 2023; 21(1):517.

PMID: 37525240 PMC: 10391987. DOI: 10.1186/s12967-023-04387-x.


References
1.
Cruz D, De Cal M, Garzotto F, Perazella M, Lentini P, Corradi V . Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2009; 36(3):444-51. PMC: 2820221. DOI: 10.1007/s00134-009-1711-1. View

2.
Daubin D, Cristol J, Dupuy A, Kuster N, Besnard N, Platon L . Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients. PLoS One. 2017; 12(1):e0169674. PMC: 5234791. DOI: 10.1371/journal.pone.0169674. View

3.
Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M . Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm. 2005; 2005(3):175-9. PMC: 1526470. DOI: 10.1155/MI.2005.175. View

4.
Sabbisetti V, Waikar S, Antoine D, Smiles A, Wang C, Ravisankar A . Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014; 25(10):2177-86. PMC: 4178434. DOI: 10.1681/ASN.2013070758. View

5.
Torregrosa I, Montoliu C, Urios A, Andres-Costa M, Gimenez-Garzo C, Juan I . Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Heart Vessels. 2014; 30(6):703-11. DOI: 10.1007/s00380-014-0538-z. View